1 Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F, Ricardo AC. Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management. Kidney Int Rep 2017; 2: 94-107.
2 Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care 2013; 39: 140-50.
3 Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 2009; 4: 1057-64.
4 Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant 2011; 26: 1628-34.
5 Novak M, Molnar MZ, Szeifert L, Kovacs AZ, Vamos EP, Zoller R, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527-34.
6 El-Majzoub S, Mucsi I, Li M, Moussaoui G, Lipman ML, Looper KJ, et al. Psychosocial Distress and Health Service Utilization in Patients Undergoing Hemodialysis: A Prospective Study. Psychosomatics 2019; 60: 385-92.
7 Cukor D, Coplan J, Brown C, Friedman S, Cromwell-Smith A, Peterson RA, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol 2007; 2: 484-90.
8 Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int 2009; 75: 1223-9.
9 Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis 2013; 62: 493-505.
10 Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in chronic kidney disease 2007; 14: 82-99.
11 Manns B, Hemmelgarn B, Lillie E, Dip SCPG, Cyr A, Gladish M, et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephro 2014; 9: 1813 - 21.
12 Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2007; 2: 960-7.
13 Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 2004; 91: 1905-10.
14 Kroenke K. Enhancing the clinical utility of depression screening. CMAJ 2012; 184: 281-2.
15 Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Gheorghe A, Keeley T, et al. Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review. PLoS One 2017; 12: e0179733.
16 Flythe JE, Hilliard T, Castillo G, Ikeler K, Orazi J, Abdel-Rahman E, et al. Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study. Clin J Am Soc Nephro 2018; 13: 735-45.
17 Flythe JE, Hilliard T, Lumby E, Castillo G, Orazi J, Abdel-Rahman EM, et al. Fostering Innovation in Symptom Management among Hemodialysis Patients: Paths Forward for Insomnia, Muscle Cramps, and Fatigue. Clin J Am Soc Nephro 2019; 14: 150-60.
18 Evans JM, Glazer A, Lum R, Heale E, MacKinnon M, Blake PG, et al. Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal. Clin J Am Soc Nephrol Cjasn 2020.
19 Johnson JA, Sayah FA, Buzinski R, Corradetti B, Davison SN, Elliott MJ, et al. A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol. Bmc Health Serv Res 2020; 20: 731.
20 Hui D, Bruera E. The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments. J Pain Symptom Manage 2017; 53: 630-43.
21 Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Journal of palliative care 1991; 7: 6-9.
22 Watanabe SM, Nekolaichuk CL, Beaumont C. The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psycho‐Oncology 2012; 21: 977-85.
23 Nipp RD, El-Jawahri A, Ruddy M, Fuh C, Temel B, D'Arpino SM, et al. Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer. Ann Oncol 2019; 30: 274-80.
24 Cancer Care Ontario. Interactive Symptom Assessment and Collection (ISAAC) Tool. 2017, Nov, 7.
25 Han B, Wu X, Guo Y. Improvement of fatigue after vitamin D supplementation in kidney transplant recipients. Medicine 2017; 96: e6918.
26 Nieder C, Kampe TA. Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy. Cureus 2018; 10: e2032.
27 Hui D, Titus A, Curtis T, Ho-Nguyen VT, Frederickson D, Wray C, et al. Implementation of the Edmonton Symptom Assessment System for Symptom Distress Screening at a Community Cancer Center: A Pilot Program. Oncologist 2017; 22: 995-1001.
28 Savard J, Ivers H. Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed. Support Care Cancer 2019; 27: 3777-83.
29 Dano S, Pokarowski M, Liao B, Tang E, Ekundayo O, Li V, et al. Evaluating symptom burden in kidney transplant recipients: validation of the revised Edmonton Symptom Assessment System for kidney transplant recipients - a single-center, cross-sectional study. Transpl Int 2020.
30 Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 3189-95.
31 Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int 2006; 69: 1621-5.
32 Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
33 Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-32.
34 Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-7.
35 Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine 2001; 16: 606-13.
36 Committee BRAKC. Depression and anxiety: The role of kidney care clinics. Vancouver: BC Renal Agency. 2015.
37 Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature. JAMA 2017; 318: 1377-84.
38 Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med 2013; 4: 627-35.
39 Clayton P. CUTPT: Stata module for empirical estimation of cutpoint for a diagnostic test. 2013.
40 Maceneaney PM, Malone DE. The Meaning of Diagnostic Test Results: A Spreadsheet for Swift Data Analysis. Clinical Radiology 2000; 55: 227-35.
41 Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 2013; 84: 179-91.
42 Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62: 199-207.
43 Bagha SM, Macedo A, Jacks LM, Lo C, Zimmermann C, Rodin G, et al. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care (Engl) 2013; 22: 60-9.
44 Collister D, Rodrigues JC, Mazzetti A, Salisbury K, Morosin L, Rabbat C, et al. Single Questions for the Screening of Anxiety and Depression in Hemodialysis. Can J Kidney Health Dis 2019; 6: 2054358118825441.
45 Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 2006; 9: 296-303.
46 Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007; 25: 4670-81.
47 Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000; 88: 2164-71.
48 Salminen E, Clemens KE, Syrjanen K, Salmenoja H. Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland. Support Care Cancer 2008; 16: 3-8.